nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenamide—CYP2C9—Rosuvastatin—atherosclerosis	0.137	0.267	CbGbCtD
Diclofenamide—CYP2C9—Simvastatin—atherosclerosis	0.128	0.248	CbGbCtD
Diclofenamide—CYP2C9—Lovastatin—atherosclerosis	0.125	0.243	CbGbCtD
Diclofenamide—CYP2C9—Pravastatin—atherosclerosis	0.125	0.243	CbGbCtD
Diclofenamide—Hepatic failure—Rosuvastatin—atherosclerosis	0.00915	0.026	CcSEcCtD
Diclofenamide—Hyperuricaemia—Niacin—atherosclerosis	0.00889	0.0252	CcSEcCtD
Diclofenamide—Blood uric acid increased—Niacin—atherosclerosis	0.00839	0.0238	CcSEcCtD
Diclofenamide—Hepatic failure—Lovastatin—atherosclerosis	0.00775	0.022	CcSEcCtD
Diclofenamide—Hepatic failure—Ezetimibe—atherosclerosis	0.0076	0.0216	CcSEcCtD
Diclofenamide—Hepatic failure—Simvastatin—atherosclerosis	0.00725	0.0206	CcSEcCtD
Diclofenamide—Hepatic failure—Pravastatin—atherosclerosis	0.00656	0.0186	CcSEcCtD
Diclofenamide—Weight decreased—Pravastatin—atherosclerosis	0.00461	0.0131	CcSEcCtD
Diclofenamide—Confusional state—Rosuvastatin—atherosclerosis	0.00407	0.0116	CcSEcCtD
Diclofenamide—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00396	0.0112	CcSEcCtD
Diclofenamide—Tremor—Lovastatin—atherosclerosis	0.00393	0.0112	CcSEcCtD
Diclofenamide—Tinnitus—Niacin—atherosclerosis	0.00386	0.011	CcSEcCtD
Diclofenamide—Tinnitus—Pravastatin—atherosclerosis	0.0038	0.0108	CcSEcCtD
Diclofenamide—Leukopenia—Lovastatin—atherosclerosis	0.00376	0.0107	CcSEcCtD
Diclofenamide—Tremor—Simvastatin—atherosclerosis	0.00368	0.0104	CcSEcCtD
Diclofenamide—Paraesthesia—Rosuvastatin—atherosclerosis	0.00363	0.0103	CcSEcCtD
Diclofenamide—Dyspepsia—Rosuvastatin—atherosclerosis	0.00356	0.0101	CcSEcCtD
Diclofenamide—Tension—Niacin—atherosclerosis	0.00354	0.01	CcSEcCtD
Diclofenamide—Leukopenia—Simvastatin—atherosclerosis	0.00351	0.00998	CcSEcCtD
Diclofenamide—Nervousness—Niacin—atherosclerosis	0.0035	0.00994	CcSEcCtD
Diclofenamide—Tension—Pravastatin—atherosclerosis	0.00348	0.00989	CcSEcCtD
Diclofenamide—Constipation—Rosuvastatin—atherosclerosis	0.00345	0.00981	CcSEcCtD
Diclofenamide—Confusional state—Lovastatin—atherosclerosis	0.00345	0.00981	CcSEcCtD
Diclofenamide—Nervousness—Pravastatin—atherosclerosis	0.00345	0.00979	CcSEcCtD
Diclofenamide—Confusional state—Ezetimibe—atherosclerosis	0.00339	0.00962	CcSEcCtD
Diclofenamide—Thrombocytopenia—Lovastatin—atherosclerosis	0.00335	0.00952	CcSEcCtD
Diclofenamide—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00333	0.00946	CcSEcCtD
Diclofenamide—Tremor—Pravastatin—atherosclerosis	0.00332	0.00944	CcSEcCtD
Diclofenamide—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00329	0.00934	CcSEcCtD
Diclofenamide—Anorexia—Lovastatin—atherosclerosis	0.00326	0.00927	CcSEcCtD
Diclofenamide—Confusional state—Simvastatin—atherosclerosis	0.00323	0.00917	CcSEcCtD
Diclofenamide—Leukopenia—Niacin—atherosclerosis	0.00323	0.00916	CcSEcCtD
Diclofenamide—Leukopenia—Pravastatin—atherosclerosis	0.00318	0.00902	CcSEcCtD
Diclofenamide—Thrombocytopenia—Simvastatin—atherosclerosis	0.00314	0.00891	CcSEcCtD
Diclofenamide—Paraesthesia—Lovastatin—atherosclerosis	0.00307	0.00873	CcSEcCtD
Diclofenamide—Anorexia—Simvastatin—atherosclerosis	0.00305	0.00867	CcSEcCtD
Diclofenamide—Paraesthesia—Ezetimibe—atherosclerosis	0.00302	0.00857	CcSEcCtD
Diclofenamide—Dyspepsia—Lovastatin—atherosclerosis	0.00301	0.00856	CcSEcCtD
Diclofenamide—Decreased appetite—Lovastatin—atherosclerosis	0.00298	0.00845	CcSEcCtD
Diclofenamide—Dyspepsia—Ezetimibe—atherosclerosis	0.00296	0.0084	CcSEcCtD
Diclofenamide—Fatigue—Lovastatin—atherosclerosis	0.00295	0.00838	CcSEcCtD
Diclofenamide—Constipation—Lovastatin—atherosclerosis	0.00293	0.00832	CcSEcCtD
Diclofenamide—Confusional state—Pravastatin—atherosclerosis	0.00292	0.00829	CcSEcCtD
Diclofenamide—Decreased appetite—Ezetimibe—atherosclerosis	0.00292	0.00829	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.0029	0.00823	CcSEcCtD
Diclofenamide—Asthenia—Rosuvastatin—atherosclerosis	0.0029	0.00823	CcSEcCtD
Diclofenamide—Fatigue—Ezetimibe—atherosclerosis	0.0029	0.00822	CcSEcCtD
Diclofenamide—Paraesthesia—Simvastatin—atherosclerosis	0.00288	0.00817	CcSEcCtD
Diclofenamide—Constipation—Ezetimibe—atherosclerosis	0.00287	0.00816	CcSEcCtD
Diclofenamide—Pruritus—Rosuvastatin—atherosclerosis	0.00286	0.00812	CcSEcCtD
Diclofenamide—Thrombocytopenia—Pravastatin—atherosclerosis	0.00283	0.00805	CcSEcCtD
Diclofenamide—Feeling abnormal—Lovastatin—atherosclerosis	0.00282	0.00801	CcSEcCtD
Diclofenamide—Dyspepsia—Simvastatin—atherosclerosis	0.00282	0.00801	CcSEcCtD
Diclofenamide—Anorexia—Niacin—atherosclerosis	0.0028	0.00796	CcSEcCtD
Diclofenamide—Decreased appetite—Simvastatin—atherosclerosis	0.00278	0.00791	CcSEcCtD
Diclofenamide—Feeling abnormal—Ezetimibe—atherosclerosis	0.00277	0.00786	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00276	0.00785	CcSEcCtD
Diclofenamide—Fatigue—Simvastatin—atherosclerosis	0.00276	0.00784	CcSEcCtD
Diclofenamide—Anorexia—Pravastatin—atherosclerosis	0.00276	0.00784	CcSEcCtD
Diclofenamide—Constipation—Simvastatin—atherosclerosis	0.00274	0.00778	CcSEcCtD
Diclofenamide—Body temperature increased—Lovastatin—atherosclerosis	0.00271	0.00769	CcSEcCtD
Diclofenamide—Dizziness—Rosuvastatin—atherosclerosis	0.00267	0.00759	CcSEcCtD
Diclofenamide—Body temperature increased—Ezetimibe—atherosclerosis	0.00265	0.00754	CcSEcCtD
Diclofenamide—Paraesthesia—Niacin—atherosclerosis	0.00264	0.0075	CcSEcCtD
Diclofenamide—Feeling abnormal—Simvastatin—atherosclerosis	0.00264	0.0075	CcSEcCtD
Diclofenamide—Somnolence—Niacin—atherosclerosis	0.00261	0.00743	CcSEcCtD
Diclofenamide—Paraesthesia—Pravastatin—atherosclerosis	0.0026	0.00738	CcSEcCtD
Diclofenamide—Dyspepsia—Niacin—atherosclerosis	0.00259	0.00735	CcSEcCtD
Diclofenamide—Decreased appetite—Niacin—atherosclerosis	0.00256	0.00726	CcSEcCtD
Diclofenamide—Dyspepsia—Pravastatin—atherosclerosis	0.00255	0.00724	CcSEcCtD
Diclofenamide—Rash—Rosuvastatin—atherosclerosis	0.00255	0.00724	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Niacin—atherosclerosis	0.00254	0.00721	CcSEcCtD
Diclofenamide—Body temperature increased—Simvastatin—atherosclerosis	0.00253	0.00719	CcSEcCtD
Diclofenamide—Headache—Rosuvastatin—atherosclerosis	0.00253	0.00719	CcSEcCtD
Diclofenamide—Decreased appetite—Pravastatin—atherosclerosis	0.00252	0.00715	CcSEcCtD
Diclofenamide—Fatigue—Pravastatin—atherosclerosis	0.0025	0.00709	CcSEcCtD
Diclofenamide—Constipation—Pravastatin—atherosclerosis	0.00248	0.00703	CcSEcCtD
Diclofenamide—Asthenia—Lovastatin—atherosclerosis	0.00246	0.00698	CcSEcCtD
Diclofenamide—Pruritus—Lovastatin—atherosclerosis	0.00242	0.00688	CcSEcCtD
Diclofenamide—Asthenia—Ezetimibe—atherosclerosis	0.00241	0.00684	CcSEcCtD
Diclofenamide—Nausea—Rosuvastatin—atherosclerosis	0.0024	0.00682	CcSEcCtD
Diclofenamide—Feeling abnormal—Pravastatin—atherosclerosis	0.00239	0.00678	CcSEcCtD
Diclofenamide—Pruritus—Ezetimibe—atherosclerosis	0.00238	0.00675	CcSEcCtD
Diclofenamide—Body temperature increased—Niacin—atherosclerosis	0.00232	0.0066	CcSEcCtD
Diclofenamide—Asthenia—Simvastatin—atherosclerosis	0.0023	0.00653	CcSEcCtD
Diclofenamide—Body temperature increased—Pravastatin—atherosclerosis	0.00229	0.0065	CcSEcCtD
Diclofenamide—Pruritus—Simvastatin—atherosclerosis	0.00227	0.00644	CcSEcCtD
Diclofenamide—Dizziness—Lovastatin—atherosclerosis	0.00226	0.00643	CcSEcCtD
Diclofenamide—Dizziness—Ezetimibe—atherosclerosis	0.00222	0.00631	CcSEcCtD
Diclofenamide—Vomiting—Lovastatin—atherosclerosis	0.00218	0.00618	CcSEcCtD
Diclofenamide—Rash—Lovastatin—atherosclerosis	0.00216	0.00613	CcSEcCtD
Diclofenamide—Headache—Lovastatin—atherosclerosis	0.00214	0.00609	CcSEcCtD
Diclofenamide—Vomiting—Ezetimibe—atherosclerosis	0.00214	0.00606	CcSEcCtD
Diclofenamide—Dizziness—Simvastatin—atherosclerosis	0.00212	0.00602	CcSEcCtD
Diclofenamide—Rash—Ezetimibe—atherosclerosis	0.00212	0.00601	CcSEcCtD
Diclofenamide—Asthenia—Niacin—atherosclerosis	0.00211	0.00599	CcSEcCtD
Diclofenamide—Headache—Ezetimibe—atherosclerosis	0.0021	0.00598	CcSEcCtD
Diclofenamide—Pruritus—Niacin—atherosclerosis	0.00208	0.00591	CcSEcCtD
Diclofenamide—Asthenia—Pravastatin—atherosclerosis	0.00208	0.0059	CcSEcCtD
Diclofenamide—Pruritus—Pravastatin—atherosclerosis	0.00205	0.00582	CcSEcCtD
Diclofenamide—Vomiting—Simvastatin—atherosclerosis	0.00204	0.00578	CcSEcCtD
Diclofenamide—Nausea—Lovastatin—atherosclerosis	0.00203	0.00578	CcSEcCtD
Diclofenamide—Rash—Simvastatin—atherosclerosis	0.00202	0.00574	CcSEcCtD
Diclofenamide—Headache—Simvastatin—atherosclerosis	0.00201	0.0057	CcSEcCtD
Diclofenamide—Nausea—Ezetimibe—atherosclerosis	0.00199	0.00567	CcSEcCtD
Diclofenamide—Dizziness—Niacin—atherosclerosis	0.00194	0.00552	CcSEcCtD
Diclofenamide—Dizziness—Pravastatin—atherosclerosis	0.00191	0.00544	CcSEcCtD
Diclofenamide—Nausea—Simvastatin—atherosclerosis	0.0019	0.0054	CcSEcCtD
Diclofenamide—Vomiting—Niacin—atherosclerosis	0.00187	0.00531	CcSEcCtD
Diclofenamide—Rash—Niacin—atherosclerosis	0.00185	0.00527	CcSEcCtD
Diclofenamide—Headache—Niacin—atherosclerosis	0.00184	0.00523	CcSEcCtD
Diclofenamide—Vomiting—Pravastatin—atherosclerosis	0.00184	0.00523	CcSEcCtD
Diclofenamide—Rash—Pravastatin—atherosclerosis	0.00183	0.00519	CcSEcCtD
Diclofenamide—Headache—Pravastatin—atherosclerosis	0.00181	0.00515	CcSEcCtD
Diclofenamide—Nausea—Niacin—atherosclerosis	0.00175	0.00496	CcSEcCtD
Diclofenamide—Nausea—Pravastatin—atherosclerosis	0.00172	0.00488	CcSEcCtD
Diclofenamide—CA5A—Metabolism—MTHFR—atherosclerosis	0.000133	0.00101	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—MTHFR—atherosclerosis	0.000133	0.00101	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—CD36—atherosclerosis	0.000131	0.000992	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—CD36—atherosclerosis	0.000131	0.000992	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—PPARA—atherosclerosis	0.000131	0.000988	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—PPARA—atherosclerosis	0.000131	0.000988	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—CETP—atherosclerosis	0.000131	0.000986	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—GSTM1—atherosclerosis	0.000131	0.000986	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—ABCA1—atherosclerosis	0.00013	0.000983	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—AGT—atherosclerosis	0.00013	0.000982	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.000129	0.000972	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—LPL—atherosclerosis	0.000128	0.000967	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—APOE—atherosclerosis	0.000127	0.000962	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—AGT—atherosclerosis	0.000127	0.000957	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—AGT—atherosclerosis	0.000127	0.000957	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—CAV1—atherosclerosis	0.000126	0.000953	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—APOA1—atherosclerosis	0.000126	0.000951	CbGpPWpGaD
Diclofenamide—CYP2C9—Biological oxidations—GSTM1—atherosclerosis	0.000126	0.000948	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—GPX1—atherosclerosis	0.000125	0.000944	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—SCARB1—atherosclerosis	0.000125	0.000944	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—ABCA1—atherosclerosis	0.000125	0.000943	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—MTHFR—atherosclerosis	0.000125	0.00094	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—MTHFR—atherosclerosis	0.000125	0.00094	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—APOE—atherosclerosis	0.000124	0.000938	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—APOE—atherosclerosis	0.000124	0.000938	CbGpPWpGaD
Diclofenamide—CYP2C9—Metapathway biotransformation—GSTM1—atherosclerosis	0.000124	0.000935	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—CAV1—atherosclerosis	0.000123	0.000929	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—CAV1—atherosclerosis	0.000123	0.000929	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—APOA1—atherosclerosis	0.000123	0.000927	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—APOA1—atherosclerosis	0.000123	0.000927	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PPARA—atherosclerosis	0.000122	0.000922	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PPARA—atherosclerosis	0.000122	0.000922	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—CD36—atherosclerosis	0.000122	0.000919	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.000121	0.000914	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.000121	0.000914	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—ABCA1—atherosclerosis	0.00012	0.000904	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.000119	0.000897	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—AGT—atherosclerosis	0.000118	0.000893	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—AGT—atherosclerosis	0.000118	0.000893	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—HMGCR—atherosclerosis	0.000118	0.000891	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.000117	0.000882	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—APOE—atherosclerosis	0.000116	0.000875	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—APOE—atherosclerosis	0.000116	0.000875	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—MTHFR—atherosclerosis	0.000115	0.000871	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—PIK3CG—atherosclerosis	0.000115	0.000868	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—CAV1—atherosclerosis	0.000115	0.000867	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—CAV1—atherosclerosis	0.000115	0.000867	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—APOA1—atherosclerosis	0.000115	0.000865	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—APOA1—atherosclerosis	0.000115	0.000865	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PPARA—atherosclerosis	0.000113	0.000854	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—PIK3CG—atherosclerosis	0.000112	0.000846	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—PIK3CG—atherosclerosis	0.000112	0.000846	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—HMOX1—atherosclerosis	0.000112	0.000843	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—PPARG—atherosclerosis	0.000111	0.000838	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—AGT—atherosclerosis	0.00011	0.000828	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—INS—atherosclerosis	0.000109	0.000822	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—PPARG—atherosclerosis	0.000108	0.000817	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—PPARG—atherosclerosis	0.000108	0.000817	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.000108	0.000815	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—APOE—atherosclerosis	0.000107	0.000811	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—IL6—atherosclerosis	0.000107	0.00081	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—HMOX1—atherosclerosis	0.000107	0.000809	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—APOB—atherosclerosis	0.000107	0.000808	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—CAV1—atherosclerosis	0.000106	0.000803	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—APOA1—atherosclerosis	0.000106	0.000802	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—INS—atherosclerosis	0.000106	0.000801	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—INS—atherosclerosis	0.000106	0.000801	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—ABCA1—atherosclerosis	0.000105	0.000794	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PIK3CG—atherosclerosis	0.000105	0.00079	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PIK3CG—atherosclerosis	0.000105	0.00079	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—GSTM1—atherosclerosis	0.000104	0.000786	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—HMOX1—atherosclerosis	0.000103	0.000775	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—APOB—atherosclerosis	0.000103	0.000775	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.000102	0.000773	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.000102	0.000773	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.000102	0.000773	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.000102	0.000773	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—LPL—atherosclerosis	0.000102	0.000771	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.000101	0.000763	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PPARG—atherosclerosis	0.000101	0.000762	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PPARG—atherosclerosis	0.000101	0.000762	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—ALB—atherosclerosis	9.98e-05	0.000753	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—GSTM1—atherosclerosis	9.98e-05	0.000753	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—GPX1—atherosclerosis	9.97e-05	0.000753	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—INS—atherosclerosis	9.91e-05	0.000748	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—INS—atherosclerosis	9.91e-05	0.000748	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—APOB—atherosclerosis	9.84e-05	0.000743	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—LPL—atherosclerosis	9.8e-05	0.00074	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	9.76e-05	0.000737	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—ALB—atherosclerosis	9.73e-05	0.000734	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—ALB—atherosclerosis	9.73e-05	0.000734	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—CD36—atherosclerosis	9.71e-05	0.000733	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PIK3CG—atherosclerosis	9.7e-05	0.000732	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—GSTM1—atherosclerosis	9.57e-05	0.000722	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—GPX1—atherosclerosis	9.56e-05	0.000722	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—NOS3—atherosclerosis	9.55e-05	0.000721	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—LPL—atherosclerosis	9.39e-05	0.000709	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	9.36e-05	0.000707	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PPARG—atherosclerosis	9.36e-05	0.000706	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—CD36—atherosclerosis	9.31e-05	0.000703	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—NOS3—atherosclerosis	9.31e-05	0.000702	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—NOS3—atherosclerosis	9.31e-05	0.000702	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—MTHFR—atherosclerosis	9.2e-05	0.000695	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—INS—atherosclerosis	9.18e-05	0.000693	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—GPX1—atherosclerosis	9.17e-05	0.000692	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—ALB—atherosclerosis	9.08e-05	0.000686	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—ALB—atherosclerosis	9.08e-05	0.000686	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—HMOX1—atherosclerosis	9.03e-05	0.000682	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PPARA—atherosclerosis	9.03e-05	0.000681	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	9.01e-05	0.00068	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—CD36—atherosclerosis	8.93e-05	0.000674	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—LDLRAP1—atherosclerosis	8.9e-05	0.000672	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—MTHFR—atherosclerosis	8.82e-05	0.000666	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—AGT—atherosclerosis	8.74e-05	0.00066	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—PTGS2—atherosclerosis	8.73e-05	0.000659	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	8.7e-05	0.000657	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—NOS3—atherosclerosis	8.69e-05	0.000656	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—NOS3—atherosclerosis	8.69e-05	0.000656	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PPARA—atherosclerosis	8.66e-05	0.000653	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—APOB—atherosclerosis	8.65e-05	0.000653	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—APOE—atherosclerosis	8.57e-05	0.000647	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—PTGS2—atherosclerosis	8.51e-05	0.000642	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—PTGS2—atherosclerosis	8.51e-05	0.000642	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—CAV1—atherosclerosis	8.49e-05	0.000641	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—APOA1—atherosclerosis	8.47e-05	0.000639	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—MTHFR—atherosclerosis	8.46e-05	0.000638	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—GSTM1—atherosclerosis	8.41e-05	0.000635	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—ALB—atherosclerosis	8.41e-05	0.000635	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—AGT—atherosclerosis	8.38e-05	0.000633	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PLTP—atherosclerosis	8.37e-05	0.000632	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PPARA—atherosclerosis	8.3e-05	0.000626	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—LPL—atherosclerosis	8.26e-05	0.000623	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—APOE—atherosclerosis	8.21e-05	0.00062	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—CAV1—atherosclerosis	8.14e-05	0.000614	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—APOA1—atherosclerosis	8.12e-05	0.000613	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—GPX1—atherosclerosis	8.06e-05	0.000608	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—NOS3—atherosclerosis	8.05e-05	0.000607	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—AGT—atherosclerosis	8.04e-05	0.000607	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PTGS2—atherosclerosis	7.95e-05	0.0006	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PTGS2—atherosclerosis	7.95e-05	0.0006	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—APOE—atherosclerosis	7.87e-05	0.000594	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—CD36—atherosclerosis	7.85e-05	0.000592	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—CAV1—atherosclerosis	7.8e-05	0.000589	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—APOA1—atherosclerosis	7.78e-05	0.000588	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	7.76e-05	0.000585	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PIK3CG—atherosclerosis	7.73e-05	0.000584	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	7.71e-05	0.000582	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	7.66e-05	0.000578	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	7.48e-05	0.000565	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PPARG—atherosclerosis	7.46e-05	0.000563	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—MTHFR—atherosclerosis	7.44e-05	0.000561	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PIK3CG—atherosclerosis	7.41e-05	0.000559	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PTGS2—atherosclerosis	7.36e-05	0.000556	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—INS—atherosclerosis	7.32e-05	0.000552	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PPARA—atherosclerosis	7.3e-05	0.000551	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—LTA4H—atherosclerosis	7.26e-05	0.000548	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ABCG8—atherosclerosis	7.26e-05	0.000548	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	7.17e-05	0.000541	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PPARG—atherosclerosis	7.15e-05	0.00054	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PIK3CG—atherosclerosis	7.11e-05	0.000536	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—AGT—atherosclerosis	7.07e-05	0.000533	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—INS—atherosclerosis	7.02e-05	0.00053	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—APOE—atherosclerosis	6.92e-05	0.000523	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—CAV1—atherosclerosis	6.86e-05	0.000518	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PPARG—atherosclerosis	6.86e-05	0.000518	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—APOA1—atherosclerosis	6.84e-05	0.000517	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	6.77e-05	0.000511	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—INS—atherosclerosis	6.73e-05	0.000508	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—ALB—atherosclerosis	6.71e-05	0.000506	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—ALB—atherosclerosis	6.43e-05	0.000486	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—NOS3—atherosclerosis	6.42e-05	0.000484	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PIK3CG—atherosclerosis	6.25e-05	0.000472	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—ALB—atherosclerosis	6.17e-05	0.000466	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—NOS3—atherosclerosis	6.15e-05	0.000464	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	6.03e-05	0.000455	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PPARG—atherosclerosis	6.03e-05	0.000455	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—INS—atherosclerosis	5.91e-05	0.000446	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—NOS3—atherosclerosis	5.9e-05	0.000445	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PTGS2—atherosclerosis	5.87e-05	0.000443	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ABCG1—atherosclerosis	5.74e-05	0.000433	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PTGS2—atherosclerosis	5.63e-05	0.000425	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—ALB—atherosclerosis	5.42e-05	0.000409	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PTGS2—atherosclerosis	5.4e-05	0.000407	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—FABP4—atherosclerosis	5.39e-05	0.000407	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—LCAT—atherosclerosis	5.39e-05	0.000407	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—APOA4—atherosclerosis	5.3e-05	0.0004	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CYP7A1—atherosclerosis	5.2e-05	0.000393	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—NOS3—atherosclerosis	5.19e-05	0.000391	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	4.96e-05	0.000374	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CYP27A1—atherosclerosis	4.81e-05	0.000363	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PTGS2—atherosclerosis	4.74e-05	0.000358	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	4.73e-05	0.000357	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	4.62e-05	0.000349	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—APOA2—atherosclerosis	4.56e-05	0.000344	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	4.56e-05	0.000344	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ALOX15—atherosclerosis	4.56e-05	0.000344	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	4.56e-05	0.000344	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ABCG5—atherosclerosis	4.5e-05	0.00034	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	4.5e-05	0.000339	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—AKT1—atherosclerosis	4.39e-05	0.000331	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—LPA—atherosclerosis	4.35e-05	0.000328	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—AKT1—atherosclerosis	4.28e-05	0.000323	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—AKT1—atherosclerosis	4.28e-05	0.000323	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—BGN—atherosclerosis	4.21e-05	0.000318	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	4.18e-05	0.000316	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—APOA5—atherosclerosis	4.17e-05	0.000315	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	4.05e-05	0.000306	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	4.01e-05	0.000303	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—AKT1—atherosclerosis	3.99e-05	0.000301	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—AKT1—atherosclerosis	3.99e-05	0.000301	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	3.97e-05	0.000299	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	3.93e-05	0.000297	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	3.92e-05	0.000296	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ALOX5—atherosclerosis	3.88e-05	0.000293	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—AKT1—atherosclerosis	3.7e-05	0.000279	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	3.58e-05	0.00027	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NAMPT—atherosclerosis	3.48e-05	0.000262	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	3.46e-05	0.000261	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—LIPC—atherosclerosis	3.45e-05	0.000261	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—APOC3—atherosclerosis	3.43e-05	0.000259	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—LDLR—atherosclerosis	3.41e-05	0.000258	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CETP—atherosclerosis	3.33e-05	0.000252	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SCARB1—atherosclerosis	3.19e-05	0.000241	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	3.11e-05	0.000235	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—HMGCR—atherosclerosis	3.01e-05	0.000228	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—AKT1—atherosclerosis	2.95e-05	0.000223	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—AKT1—atherosclerosis	2.83e-05	0.000213	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.72e-05	0.000205	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—AKT1—atherosclerosis	2.71e-05	0.000205	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ABCA1—atherosclerosis	2.69e-05	0.000203	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—AKT1—atherosclerosis	2.38e-05	0.00018	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—HMOX1—atherosclerosis	2.3e-05	0.000174	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—APOB—atherosclerosis	2.21e-05	0.000167	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GSTM1—atherosclerosis	2.15e-05	0.000162	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—LPL—atherosclerosis	2.11e-05	0.000159	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GPX1—atherosclerosis	2.06e-05	0.000155	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CD36—atherosclerosis	2e-05	0.000151	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—MTHFR—atherosclerosis	1.9e-05	0.000143	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PPARA—atherosclerosis	1.86e-05	0.000141	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—AGT—atherosclerosis	1.8e-05	0.000136	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—APOE—atherosclerosis	1.77e-05	0.000133	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CAV1—atherosclerosis	1.75e-05	0.000132	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—APOA1—atherosclerosis	1.75e-05	0.000132	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PIK3CG—atherosclerosis	1.59e-05	0.00012	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PPARG—atherosclerosis	1.54e-05	0.000116	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—INS—atherosclerosis	1.51e-05	0.000114	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ALB—atherosclerosis	1.38e-05	0.000104	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NOS3—atherosclerosis	1.32e-05	9.99e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PTGS2—atherosclerosis	1.21e-05	9.14e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—AKT1—atherosclerosis	6.09e-06	4.59e-05	CbGpPWpGaD
